Linperlisib Recruiting Phase 2 Trials for Relapsed/Refractory Large Granular T Lymphocytic Leukemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT06224257Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia